Skip to main content

Advertisement

Figure 1 | Stem Cell Research & Therapy

Figure 1

From: Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke

Figure 1

Flow cytometry characterization of bone marrow-derived mesenchymal (BM-MSC) and adipose tissue-derived mesenchymal (AD-MSC) cells before administration. Both BM-MSC (up) and AD-MSC (down) were analyzed before administration. MSC expressed markers CD29 and CD90 (left) and were negative for CD45 and CD11b. Both BM-MSC and AD-MSC showed similar results.

Back to article page